Development and validation of a machine learning-based diagnostic system for 22 pediatric respiratory pathogens: a
Dubin Su1,2, Qun Chen1,3, Ruizhi Xu1,2
1Institute for Clinical Medical Research, the First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
NPJ Digital Medicine
|May 29, 2026
Summary
A new system, Pathogen Diagnostic System for Pediatric Respiratory Infections (Pathog-PDx), accurately identifies pediatric respiratory pathogens early. This aids in timely, targeted treatment for better child health outcomes.
Area of Science:
- Pediatric infectious diseases
- Medical informatics
- Computational biology
Background:
- Respiratory tract infections (RTIs) are a major cause of childhood illness.
- Accurate pathogen identification is essential for effective treatment of pediatric RTIs.
- Current diagnostic methods can be slow, delaying targeted therapy.
Purpose of the Study:
- To develop and validate an interpretable diagnostic system, Pathog-PDx, for early identification of respiratory pathogens in children.
- To assess the real-world applicability of the Pathog-PDx model.
- To provide a decision support tool for clinicians treating pediatric RTIs.
Main Methods:
- Developed an interpretable Pathogen Diagnostic System for Pediatric Respiratory Infections (Pathog-PDx) using 42 clinical and laboratory features from electronic health records (EHR).
- Conducted a multicenter study involving 134,500 hospitalized children for model development.
- Performed prospective validation on an independent cohort of 1338 children.
Main Results:
- Pathog-PDx accurately distinguished 22 pathogen subtypes, outperforming conventional models in identifying single and mixed infections.
- Achieved high classification performance for key pathogens like influenza virus (AUC=0.95, Sn=0.88, Sp=0.86).
- Demonstrated a mean AUC of 0.88 for various RTI pathogens.
Conclusions:
- Pathog-PDx is a validated tool for early identification of respiratory pathogens in pediatric patients.
- The system provides actionable predictions before conventional test results are available.
- Pathog-PDx has been deployed as a freely accessible web-based decision support system to guide timely and targeted therapy.
Related Concept Videos
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
